Targeting survivin for therapeutic discovery: past, present, and future promises.
Sign Up to like & getrecommendations! Published in 2017 at "Drug discovery today"
DOI: 10.1016/j.drudis.2017.05.009
Abstract: Survivin, the smallest member of the inhibitor of apoptosis protein (IAP) family, is overexpressed in cells of almost all cancers but not in most normal tissues in adults. Survivin expression is required for cancer cell… read more here.
Keywords: survivin therapeutic; discovery; targeting survivin; drug discovery ... See more keywords